Webcast: Cardiorenal Risk Reduction With Novel Non-Steroidal MRAS - Advances and Expert Perspectives |
- 0.75 ACPE Pharmacy
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Participation
|
Enduring |
|
$0.00 |
CMHC Masterclass On Demand: Frontiers in Interventional Cardiology |
- 10.00 CDE
- 10.00 ACPE Pharmacy
- 10.00 AMA PRA Category 1 Credit™
- 10.00 ANCC
- 10.00 Participation
|
Enduring |
|
$0.00 |
At the Frontiers of Care: The Emerging Role of CGM in Improving Glycemic Control and Outcomes During Pregnancy |
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
An Overview of GLP-1 RAs for CV Risk Reduction in T2DM Patients |
- 1.00 CDE
- 1.00 ABIM MOC and AMA PRA Category 1 Credit™
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
The Emerging Role of CGM for Patients with Type 2 Diabetes: Rationale, Evidence, and Practice Pearls for Integration |
- 1.00 CDE
- 1.00 ABIM MOC and AMA PRA Category 1 Credit™
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Clinical Brief: Challenges and Advances in Diabetic Kidney Disease |
- 1.00 CDE
- 1.00 ABIM MOC and AMA PRA Category 1 Credit™
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Clinical Brief: Prevention and Treatment of Influenza in High-Risk Patients with Cardiometabolic Comorbidities |
- 1.00 CDE
- 1.00 ABIM MOC and AMA PRA Category 1 Credit™
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Case Study - Tackling Diabetic Kidney Disease Progression: Challenges, Advances, and Novel Approaches |
- 0.50 CDE
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |
CMHC Masterclass On Demand: Connecting the Dots in Cardiometabolic Medicine - Integrative Approaches to Improve Patient Care |
- 14.00 CDE
- 14.00 ACPE Pharmacy
- 14.00 AMA PRA Category 1 Credit™
- 14.00 ANCC
- 14.00 Participation
|
Enduring |
|
$0.00 |
CMHC Spring 2022 On Demand |
- 16.25 CDE
- 16.25 ACPE Pharmacy
- 16.25 AMA PRA Category 1 Credit™
- 16.25 ANCC
- 16.25 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium: CGM - Going Beyond HbA1c to Optimize and Individualize T2D Management |
- 0.50 CDE
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium - Assessing the Role of TAVR Across the Risk Continuum: Emerging Evidence, Evolving Guidance, and Expert Perspectives |
- 1.00 CDE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Webcast: Challenging Cases in Patients with Iron Deficiency and Heart Failure |
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |
Webcast: Advances in Screening, Diagnosis, and Treatment of Iron Deficiency in Heart Failure Patients |
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Clinical Brief: Should Diabetes Management be More Adipose-centric? |
- 0.50 CDE
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |